Report finds brain drain in AMR researchers

The USA-based AMR Industry Alliance conducted a review of publicly available data on the state of antimicrobial resistance (AMR) research and development talent, indicating that researchers are leaving the field of AMR as market dysfunction jeopardizes the investment needed to tackle this growing public health threat.

The report found that:

  • The AMR R&D workforce is limited and declining. It estimates around 3,000 AMR researchers currently active…

The full article can be found at


date 13/02/2024
source The Pharma Letter